The conversion of fibrinogen to fibrin: Recombinant fibrinogen typifies plasma fibrinogen

Blood

Volumn 89, Issue 12, 1997, Pages 4407-4414

  Gorkun, Oleg V ^b   Veklich, Yuri I ^b   Weisel, John W ^b   Lord, Susan T ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBRINOGEN; MESSENGER RNA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CROSS LINKING; DISULFIDE BOND; FIBRIN CLOT; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN CELL; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN PROCESSING; RNA PROCESSING; THROMBOCYTE AGGREGATION;

EID: 0030998485     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.12.4407     Document Type: Article

References (31)

1. Weisel JW, Stauffacher CV, Bullitt E, Cohen C: A model for fibrinogen: Domains and sequence. Science 230:1388, 1985
2. Erickson HP, Fowler WE: Electron microscopy of fibrinogen, its plasmic fragments and small polymers. Ann NY Acad Sci 408:146, 1983
3. Veklich YI, Gorkun OV, Medved LV, Nieuwenhuizen W, Weisel JW: Carboxyl-terminal portions of the a chains of fibrinogen and fibrin. Localization by electron microscopy and the effects of isolated αC fragments on polymerization. J Biol Chem 268:13577, 1993
4. Gorkun OV, Veklich YI, Medved LV, Menschen AH, Weisel JW: Role of the αC domains of fibrin in clot formation. Biochemistry 33:6986, 1994
5. Weisel JW, Veklich Y, Gorkun O: The sequence of cleavage of fibrinopeptides from fibrinogen is important for protofibril formation and enhancement of lateral aggregation in fibrin clots. J Mol Biol 232:285, 1993
6. Lorand L: Fibrinoligase: The fibrin-stabilizing factor system of blood plasma. Ann NY Acad Sci 202:6, 1972
7. Farrell DH, Thiagarajan P, Chung DW, Davie EW: Role of fibrinogen α and γ chain sites in platelet aggregation. Proc Natl Acad Sci USA 89:10729, 1992
8. Binnie CG, Hettasch JM, Strickland E, Lord ST: Characterization of purified recombinant fibrinogen: Partial phosphorylation of fibrinopeptide. Biochemistry 32:107, 1993
9. Lord ST, Strickland E, Jayjock E: Strategy for recombinant multichain protein synthesis: Fibrinogen Bβ-chain variant as a thrombin substrates. Biochemistry 35:2342, 1996
10. Rooney MM, Parise LV, Lord ST: Dissecting clot retraction and platelet aggregation. J Biol Chem 271:8553, 1996
11. Henschen AH: Human fibrinogen - structural variants and functional sites. Thromb Haemost 70:42, 1993
12. Takebe M, Soe G, Kohno I, Sugo T, Matsuda M: Calcium ion-dependent monoclonal antibody against human fibrinogen preparation, characterization, and application to flbrinogen purification. Thromb Haemost 73:662, 1995
13. Birken S, Wilner G, Confield R: Studies of the structure of canine fibrinogen. Throm Res 7:599, 1975
14. Mihalyi E: Physicochemical studies of bovine fibrinogen. IV. Ultraviolet absorption and its relation to the structure of the molecule. Biochemistry 7:208, 1968
15. Haverkate F, Koopman J, Kluft C, D'Angelo A, Cattaneo M, Mannucci PM: Fibrinogen Milano II: A congenital dysfibrinogenaemia associated with juvenile arterial and venous thrombosis. Thromb Haemost 55:131, 1986
16. Belitser VA, Varetskaja TV, Malneva GV: Fibrinogen-fibrin interaction. Biochim Biophys Acta 154:367, 1968
17. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
18. Doerner KC, White BA: Detection of glycoproteins separated by non denaturing polyacrylamide gel electrophoresis using the periodic acid-schiff stain. Anal Biochem 187:147, 1990
19. Koppert PW, Huijsman CMG, Nieuwenheizen WA: A monoclonal antibody, specific for human fibrinogen, fibrinopeptide A-containing fragments and not reacting with free fibrinopeptide A. Blood 66:503, 1985
20. Valenzuela R, Shainoff JR, DiBello PM, Urbanic DA, Anderson JM, Matsueda GR, Kudryk BJ: Immunoelectrophoretic and immunohistochemical characterization of fibrinogen derivatives in atherosclerotic aortic intimas and vascular prosthesis pseudo-intimas. Am J Pathol 141:861, 1992
21. Shiba E, Lindon JN, Kushner L, Matsueda GR, Hawiger J, Kloczewiak M, Kudryk B, Salzman EW: Antibody-detectable changes in fibrinogen adsorption affecting platelet activation on polymer surfaces. Am J Physiol 260:C965, 1991
22. Langer BG, Weisel JW, Dinauer PA, Nagaswami C, Bell WR: Deglycosylation of fibrinogen accelerates polymerization and increases lateral aggregation of fibrin fibers. J Biol Chem 263:15056, 1988
23. Holm B, Nilsen DW, Kierulf P, Godai HC: Purification and characterization of 3 fibrinogens with different molecular weights obtained from normal human plasma. Thromb Res 37:165, 1985
24. Ng AS, Lewis SD, Shafer JA: Quantifying thrombin-catalyzed release of fibrinopeptides from fibrinogen using high-performance liquid chromatography. Methods Enzymol 222:341, 1993
25. Furlan M, Rupp C, Beck E: Inhibition of fibrin polymerization by fragment D is affected by calcium, Gly-Pro-Arg and Gly-His-Arg. Biochim Biophys Acta 742:25, 1983
26. Hantgan RR, Hermans J: Assembly of fibrin. A light scattering study. J Biol Chem 254:11272, 1979
27. Weisel JW, Nagaswami C: Computer modeling of fibrin polymerization kinetics correlated with electron microscope and turbidity observations: Clot structure and assembly are kinetically controlled. Biophys J 63:111, 1992
28. Siebenlist KR, Mosesson MW, DiOrio JP, Soria J, Soria C, Caen JP: The polymerization of fibrinogen Dusart (Aα 554 Arg to Cys) after removal of carboxy terminal regions of the Aα-chains. Blood Coagul Fibrinolysis 4:61, 1993
29. Collet JP, Woodhead JL, Soria J, Soria C, Mirshahi M, Caen JP, Weisel JW: Fibrinogen Dusart: Electron microscopy of molecules, fibers and clots, and viscoelastic properties of clots. Biophys J 70:500, 1996
30. Fu Y, Grieninger G: Fib420: A normal human variant of fibrinogen with two extended α chains. Proc Natl Acad Sci USA 91:2625, 1994
31. Mosesson MW, Finlayson JS, Umfleet RA: Human fibrinogen heterogeneities. 3. Identification of chain variants. J Biol Chem 247:5223, 1972